FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084874 [Registered on: 16/04/2025] Trial Registered Prospectively
Last Modified On: 14/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparative Efficacy of Dys-Fizz Tablet and Hinguvachadi Churna in Managing Udavartini Yonivyapad 
Scientific Title of Study   A randomized controlled clinical study to compare the efficacy of dys-fizz tablet with hinguvachadi churna in the management of udavartini yonivyapad 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Divya Shingare 
Designation  PG Scholar 
Affiliation  Parul Institute of Ayurved and Research 
Address  Department of Prasuti Tantra Evum Stree Roga, Parul Institute of Ayurved and Research Parul University P.O Limda Vadodara Gujrat India Pincode-391760

Vadodara
GUJARAT
391760
India 
Phone  8408075710  
Fax    
Email  shingaredivya9@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abha L Ravi 
Designation  Associate Professor 
Affiliation  Parul Institute of Ayurved and Research 
Address  Department of Prasuti Tantra Evum Stree Roga, Parul Institute of Ayurved and Research Parul University P.O Limda Vadodara Gujrat India Pincode-391760

Vadodara
GUJARAT
391760
India 
Phone  8281578252  
Fax    
Email  abharavi22@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Divya Shingare 
Designation  PG Scholar 
Affiliation  Parul Institute of Ayurved and Research 
Address  Department of Prasuti Tantra Evum Stree Roga, Parul Institute of Ayurved and Research Parul University P.O Limda Vadodara Gujrat India Pincode-391760

Vadodara
GUJARAT
391760
India 
Phone  8408075710  
Fax    
Email  shingaredivya9@gmail.com  
 
Source of Monetary or Material Support  
Dr Divya Shingare Post Graduate Scholar Department of Prasuti Tantra Evum Stree Roga Parul Institute of Ayurved and Research Parul University P.O Limda Vadodara Gujrat India Pincode-391760 
 
Primary Sponsor  
Name  Dr Divya Shingare 
Address  Department of Prasuti Tantra Evum Stree Roga Parul Institute of Ayurved and Research Parul University P.O Limda Vadodara Gujrat India Pincode-391760 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NILL  NILL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Divya Shingare  Khemdas Hospital  OPD No. 05 Department of Prasuti Tantra Evum Stree Roga Ground Floor Khemdas Hospital Parul Institute of Ayurved and Research Parul University P.O Limda Vadodara Gujrat India Pincode-391760
Vadodara
GUJARAT 
8408075710

shingaredivya9@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PIAR-IECHR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N946||Dysmenorrhea, unspecified. Ayurveda Condition: UDAVARTINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: DYS-FIZZ TABLET, Reference: Ashtang Hridaya Chikitsa 14/31-33, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 8 Days, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -Efficacy of DYS-fizz tablet in the management of Udavartini
2Comparator ArmDrugClassical(1) Medicine Name: Hinguvachadi Choorna, Reference: Ashtang Hridaya Chikitsa 14/31-33, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 8 Days, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -Balances vata dosha and alleviate symptoms of Udavartini Yonivyapad, such as irregular menstrual flow and abdominal discomfort. Its carminative, antispasmodic, and digestive properties help in relieving pain and promoting uterine health.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Diagnosed patients of Udavartini Yonivyapad ( Patients suffering from dysmenorrhea).
Patients suffering from dysmenorrhea for the past 3 or more consecutive cycles.

 
 
ExclusionCriteria 
Details  Age below 18years and above 40 years. Patient coming with chief complaints of painful menstruation with regular.
Females with irregular menstrual cycle.
Patients having congenital anomalies leading to dysmenorrhea.
Patient with IUD /oral contraceptives.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
DYS-FIZZ tablet is more effective than hinguvachadi choorna in management of udavartini yonivyapad  BT- 0th Day
DT- 4th Day of 1st and 2nd cycle of Menstruation
AT- 12th Week
Treatment Duration- 1st 6days of expected munstruation date and 2days of menses for 2cycle
Assesment on 4th Day of menses
Final Assesment on 12th week 
 
Secondary Outcome  
Outcome  TimePoints 
Hinguvachadi choorna is equal effective as DYS-FIZZ tablet in udavartini yonivyapad  BT- 0th Day
DT- 4th Day of 1st & 2nd cycle of Menstruation
AT- 12th Week
Treatment Duration- 1st 6days of expected munstruation date & 2days of menses for 2cycle
Assesment on 4th Day of menses
Final Assesment on 12th week 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   21/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Dysmenorrhea, or painful menstruation, affects approximately 70.1% of women in India. Understanding this condition is crucial for improving quality of life and daily functioning. While modern medicine offers temporary relief, Ayurveda provides a holistic approach, particularly through the study of Udavartini Yonivyapad, a type of dysmenorrhea linked to imbalanced Vata dosha. Ayurvedic treatments focus on addressing the root cause, such as balancing Vata through dietary changes, lifestyle modifications, and herbal remedies. This study aims to compare the effectiveness of DYS-fizz tablet and Hinguvachadi Churna in managing Udavartini Yonivyapad. The study will involve 80 patients diagnosed with dysmenorrhea, randomly divided into two groups, with each receiving one of the treatments for three months. Outcomes will be assessed using a range of criteria, including pain intensity, working ability, and menstrual symptoms. The research hopes to bridge Ayurvedic and modern treatments, offering more effective, personalized options for dysmenorrhea management.

 
Close